Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Lantern Pharma Inc.
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-09-02
Sale
2022-09-07
4:55 pm
Lantern Pharma Inc. LTRN Fletcher Aaron G.L.
BIOS Fund I LP
BIOS Fund I QP LP
BIOS Fund II LP
BIOS Fund II QP LP
BIOS Fund II NT LP
Bios Equity Partners LP
Bios Equity Partners II LP
BIOS Capital Management LP
BIOS Advisors GP LLC
10% Owner
6,445 $5.2 $33,514 1,889,456
(Indirect)
View
2022-09-02
Sale
2022-09-07
4:54 pm
Lantern Pharma Inc. LTRN Kreis Leslie W.
Cavu Management LP
Cavu Advisors LLC
BP Directors LP
10% Owner
6,445 $5.2 $33,514 1,889,456
(Indirect)
View
2020-06-11
Purchase
2020-06-15
5:14 pm
Lantern Pharma Inc. LTRN KEYSER D JEFFREY
Director
10,000 $15 $150,000 10,000
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2022-09-02
Exercise
2022-09-07
4:55 pm
2018-12-17
2028-12-16
Lantern Pharma Inc. LTRN Fletcher Aaron G.L.
BIOS Fund I LP
BIOS Fund I QP LP
BIOS Fund II LP
BIOS Fund II QP LP
BIOS Fund II NT LP
Bios Equity Partners LP
Bios Equity Partners II LP
BIOS Capital Management LP
BIOS Advisors GP LLC
10% Owner
32,538 $0 1,889,456
(Indirect)
View
2022-09-02
Exercise
2022-09-07
4:55 pm
N/A
N/A
Lantern Pharma Inc. LTRN Fletcher Aaron G.L.
BIOS Fund I LP
BIOS Fund I QP LP
BIOS Fund II LP
BIOS Fund II QP LP
BIOS Fund II NT LP
Bios Equity Partners LP
Bios Equity Partners II LP
BIOS Capital Management LP
BIOS Advisors GP LLC
10% Owner
32,538 $1.03 1,889,456
(Indirect)
View
2022-09-02
Exercise
2022-09-07
4:54 pm
2018-12-17
2028-12-16
Lantern Pharma Inc. LTRN Kreis Leslie W.
Cavu Management LP
Cavu Advisors LLC
BP Directors LP
10% Owner
32,538 $0 1,889,456
(Indirect)
View
2022-09-02
Exercise
2022-09-07
4:54 pm
N/A
N/A
Lantern Pharma Inc. LTRN Kreis Leslie W.
Cavu Management LP
Cavu Advisors LLC
BP Directors LP
10% Owner
32,538 $1.03 1,889,456
(Indirect)
View
2022-08-06
Option Award
2022-08-09
4:26 pm
N/A
2032-08-06
Lantern Pharma Inc. LTRN SHARMA PANNA
CEO
100,000 $0 100,000
(Direct)
View
2022-03-17
Exercise
2022-03-21
6:11 pm
N/A
N/A
Lantern Pharma Inc. LTRN Kreis Leslie W.
Bios Equity Partners LP
Cavu Management LP
BIOS Capital Management LP
Cavu Advisors LLC
BIOS Advisors GP LLC
Fletcher Aaron G.L.
BIOS Fund I LP
BIOS Fund I QP LP
Director
10% Owner
95,779 $3.13 1,292,887
(Indirect)
View
2022-03-17
Exercise
2022-03-21
6:11 pm
2017-03-17
2022-03-17
Lantern Pharma Inc. LTRN Kreis Leslie W.
Bios Equity Partners LP
Cavu Management LP
BIOS Capital Management LP
Cavu Advisors LLC
BIOS Advisors GP LLC
Fletcher Aaron G.L.
BIOS Fund I LP
BIOS Fund I QP LP
Director
10% Owner
95,779 $0 1,292,887
(Indirect)
View
2021-11-04
Option Award
2021-11-08
5:23 pm
N/A
2031-11-04
Lantern Pharma Inc. LTRN Kreis Leslie W.
BP Directors LP
Bios Equity Partners LP
Cavu Management LP
BIOS Capital Management LP
Cavu Advisors LLC
BIOS Advisors GP LLC
Fletcher Aaron G.L.
Director
10% Owner
3,200 $0 1,764,346
(Indirect)
View
2021-11-04
Option Award
2021-11-08
4:05 pm
N/A
2031-11-04
Lantern Pharma Inc. LTRN PRENDERGAST FRANKLYN G
Director
3,200 $0 3,200
(Direct)
View
2021-11-04
Option Award
2021-11-08
4:05 pm
N/A
2031-11-04
Lantern Pharma Inc. LTRN Chandru Vijay
Director
3,200 $0 3,200
(Direct)
View
2021-11-04
Option Award
2021-11-08
4:05 pm
N/A
2031-11-04
Lantern Pharma Inc. LTRN Silberstein David S.
Director
3,200 $0 3,200
(Direct)
View
2021-11-04
Option Award
2021-11-08
4:05 pm
N/A
2031-11-04
Lantern Pharma Inc. LTRN KEYSER D JEFFREY
Director
3,200 $0 3,200
(Direct)
View
2021-10-29
Option Award
2021-11-02
4:06 pm
N/A
2031-10-29
Lantern Pharma Inc. LTRN Bhatia Kishor G.
Chief Scientific Officer
17,400 $0 17,400
(Direct)
View
2021-10-29
Option Award
2021-11-02
4:05 pm
N/A
2031-10-29
Lantern Pharma Inc. LTRN Margrave David R.
CFO
26,100 $0 26,100
(Direct)
View
2020-06-15
Conversion
2020-06-17
5:35 pm
N/A
N/A
Lantern Pharma Inc. LTRN Green Park & Golf Ventures II LLC
GPG LPI Investment LLC
Lantern 3-19 Investment LLC
Health Wildcatters Fund II LLC
Health Wildcatters LLC
Green Park & Golf Ventures LLC
Garcia Gilbert G. II
Heighten Clay M
Soderstrom Carl D
10% Owner
733,560 $0 131,697
(Indirect)
View
2020-06-15
Other
2020-06-16
7:30 pm
N/A
2030-06-14
Lantern Pharma Inc. LTRN Fletcher Aaron G.L.
BIOS Fund I LP
BIOS Fund I QP LP
BIOS Fund II LP
BIOS Fund II QP LP
BIOS Fund II NT LP
Bios Equity Partners LP
Bios Equity Partners II LP
BIOS Capital Management LP
BIOS Advisors GP LLC
10% Owner
9,135 $0 98,657
(Indirect)
View
2020-06-15
Conversion
2020-06-16
7:30 pm
N/A
N/A
Lantern Pharma Inc. LTRN Fletcher Aaron G.L.
BIOS Fund I LP
BIOS Fund I QP LP
BIOS Fund II LP
BIOS Fund II QP LP
BIOS Fund II NT LP
Bios Equity Partners LP
Bios Equity Partners II LP
BIOS Capital Management LP
BIOS Advisors GP LLC
10% Owner
2,293,804 $0 98,657
(Indirect)
View
2020-06-15
Conversion
2020-06-16
6:21 pm
N/A
N/A
Lantern Pharma Inc. LTRN Kreis Leslie W.
Cavu Management LP
Cavu Advisors LLC
BP Directors LP
Director
10% Owner
2,293,804 $0 98,657
(Indirect)
View
2020-06-15
Option Award
2020-06-16
6:21 pm
N/A
2030-06-14
Lantern Pharma Inc. LTRN Kreis Leslie W.
Cavu Management LP
Cavu Advisors LLC
BP Directors LP
Director
10% Owner
9,135 $0 98,657
(Direct)
View
2020-06-15
Option Award
2020-06-15
5:35 pm
N/A
N/A
Lantern Pharma Inc. LTRN Chandru Vijay
Director
9,135 $0 9,135
(Direct)
View
2020-06-15
Option Award
2020-06-15
5:34 pm
N/A
N/A
Lantern Pharma Inc. LTRN SHARMA PANNA
CEO
76,628 $0 76,628
(Direct)
View
2020-06-15
Option Award
2020-06-15
5:34 pm
N/A
N/A
Lantern Pharma Inc. LTRN Bhatia Kishor G.
Chief Scientific Officer
52,200 $0 52,200
(Direct)
View
2020-06-15
Option Award
2020-06-15
5:33 pm
N/A
N/A
Lantern Pharma Inc. LTRN PRENDERGAST FRANKLYN G
Director
9,135 $0 9,135
(Direct)
View
2020-06-15
Option Award
2020-06-15
5:33 pm
N/A
N/A
Lantern Pharma Inc. LTRN Silberstein David S.
Director
10% Owner
9,135 $0 9,135
(Direct)
View
2020-06-15
Option Award
2020-06-15
5:32 pm
N/A
N/A
Lantern Pharma Inc. LTRN Margrave David R.
CFO
78,300 $0 78,300
(Direct)
View
2020-06-15
Conversion
2020-06-15
5:16 pm
N/A
N/A
Lantern Pharma Inc. LTRN KEYSER D JEFFREY
Director
50,276 $0 51,062
(Direct)
View
2020-06-15
Option Award
2020-06-15
5:16 pm
N/A
N/A
Lantern Pharma Inc. LTRN KEYSER D JEFFREY
Director
9,135 $0 51,062
(Direct)
View
2020-06-10
Ownership
2020-06-10
8:23 pm
N/A
N/A
Lantern Pharma Inc. LTRN Fletcher Aaron G.L.
BIOS Fund I LP
BIOS Fund I QP LP
BIOS Fund II LP
BIOS Fund II QP LP
BIOS Fund II NT LP
Bios Equity Partners LP
Bios Equity Partners II LP
BIOS Capital Management LP
BIOS Advisors GP LLC
10% Owner
0 $0 1,968,478
(Indirect)
View
2020-06-10
Ownership
2020-06-10
7:17 pm
N/A
N/A
Lantern Pharma Inc. LTRN Kreis Leslie W.
Cavu Management LP
Cavu Advisors LLC
BP Directors LP
Director
10% Owner
0 $0 1,968,478
(Indirect)
View
2020-06-10
Ownership
2020-06-10
6:50 pm
N/A
N/A
Lantern Pharma Inc. LTRN Green Park & Golf Ventures II LLC
GPG LPI Investment LLC
Lantern 3-19 Investment LLC
Health Wildcatters Fund II LLC
Health Wildcatters LLC
Green Park & Golf Ventures LLC
Garcia Gilbert G. II
Heighten Clay M
Soderstrom Carl D
10% Owner
0 $0 675,130
(Indirect)
View
2020-06-10
Ownership
2020-06-10
5:45 pm
N/A
N/A
Lantern Pharma Inc. LTRN SHARMA PANNA
CEO
0 $0 418,858
(Direct)
View
2020-06-10
Ownership
2020-06-10
5:43 pm
N/A
N/A
Lantern Pharma Inc. LTRN Silberstein David S.
Director
10% Owner
0 $0 1,049,096
(Indirect)
View
2020-06-10
Ownership
2020-06-10
5:41 pm
N/A
N/A
Lantern Pharma Inc. LTRN KEYSER D JEFFREY
Director
0 $0 68,296
(Direct)
View
2020-06-10
Ownership
2020-06-10
5:40 pm
N/A
N/A
Lantern Pharma Inc. LTRN BIOLOGICAL MIMETICS INC
10% Owner
0 $0 1,044,000
(Direct)
View
2020-06-10
Ownership
2020-06-10
5:39 pm
N/A
N/A
Lantern Pharma Inc. LTRN Asaithambi Arunkumar
10% Owner
0 $0 485,460
(Direct)
View